CVE-2024-6151 Local Privilege escalation allows a low-privileged user to gain SYSTEM privileges

🗓️ 10 Jul 2024 20:21:25Reported by CitrixType

Local Privilege escalation in Virtual Delivery Agent for Window

Reporter	Title	Published	Views	Family All 14
BDU FSTEC	The vulnerability of the Virtual Delivery Agent component of the Citrix Virtual Apps and Desktops (CVAD) virtualization and delivery software (formerly XenApp and XenDesktop) allows a malicious individual to escalate their privileges.	26 Aug 202400:00	–	bdu_fstec
Circl	CVE-2024-6151	10 Jul 202423:54	–	circl
CISA	Citrix Releases Security Updates for Multiple Products	9 Jul 202412:00	–	cisa
Tenable Nessus	Citrix Virtual Apps and Desktops Privilege Escalation (CTX678035)	12 Jul 202400:00	–	nessus
CNNVD	Citrix Systems Virtual Apps and Desktops Security Vulnerability	10 Jul 202400:00	–	cnnvd
Citrix	Windows Virtual Delivery Agent for CVAD and Citrix DaaS Security Bulletin CVE-2024-6151	16 Jul 202419:11	–	citrix
Citrix	Citrix Virtual Apps and Desktop - Configuration, Policies and Security.	14 Jul 202400:00	–	citrix
CVE	CVE-2024-6151	10 Jul 202420:21	–	cve
Cvelist	CVE-2024-6151 Local Privilege escalation allows a low-privileged user to gain SYSTEM privileges	10 Jul 202420:21	–	cvelist
EUVD	EUVD-2024-47295	3 Oct 202520:07	–	euvd

[
  {
    "cpes": [
      "cpe:2.3:a:citrix:virtual_apps_and_desktops:*:*:*:*:*:*:*:*"
    ],
    "vendor": "citrix",
    "product": "virtual_apps_and_desktops",
    "versions": [
      {
        "status": "affected",
        "version": "0",
        "lessThan": "2402",
        "versionType": "custom"
      },
      {
        "status": "affected",
        "version": "1912 LTSR",
        "lessThan": "CU9",
        "versionType": "custom"
      },
      {
        "status": "affected",
        "version": "2203 LTSR",
        "lessThan": "CU5",
        "versionType": "custom"
      }
    ],
    "defaultStatus": "unknown"
  }
]

Source	Link
support	www.support.citrix.com/article/CTX678035

10 Jul 2024 20:21Current

7.4High risk

Vulners AI Score7.4

CVSS 48.5

EPSS0.00214

SSVC